Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia.
Por:
Cuadros M, Andrades Á, Coira IF, Baliñas C, Rodríguez MI, Álvarez-Pérez JC, Peinado P, Arenas AM, García DJ, Jiménez P, Camós-Guijosa M, Jiménez-Velasco A and Medina PP
Publicada:
25 nov 2019
Ahead of Print:
25 nov 2019
Resumen:
Filiaciones:
Cuadros M:
Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Granada, Spain
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Health Research Institute of Granada (ibs.Granada), Granada, Spain
Andrades Á:
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain
Coira IF:
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain
Baliñas C:
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain
Rodríguez MI:
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Health Research Institute of Granada (ibs.Granada), Granada, Spain
Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain
Álvarez-Pérez JC:
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Health Research Institute of Granada (ibs.Granada), Granada, Spain
Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain
Peinado P:
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain
Arenas AM:
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain
García DJ:
Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Granada, Spain
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Jiménez P:
Health Research Institute of Granada (ibs.Granada), Granada, Spain
Department of Clinical Analysis and Immunology, UGC Laboratorio Clínico, University Hospital Virgen de las Nieves, Granada, Spain
Camós-Guijosa M:
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, University of Barcelona
Institut de Recerca Hospital Sant Joan de Deu Barcelona
Jiménez-Velasco A:
Hematology Laboratory, Universitary Regional Hospital, Málaga, Spain
Medina PP:
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
Health Research Institute of Granada (ibs.Granada), Granada, Spain.
Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.
Green Published, gold
|